SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001072613-17-000141
Filing Date
2017-02-13
Accepted
2017-02-13 17:27:30
Documents
1
Group Members
ARCH VENTURE PARTNERS VII, L.P.ARCH VENTURE PARTNERS VII, LLCCLINTON BYBEEKEITH CRANDELLROBERT NELSEN

Document Format Files

Seq Description Document Type Size
1 SYROS PHARMACEUTICALS, INC. -- SCHEDULE 13G/A (AMEND. #1) syros-sch13g18036.htm SC 13G/A 189336
  Complete submission text file 0001072613-17-000141.txt   191096
Mailing Address 8755 W HIGGINS SUITE 1025 Chicago IL 60631
Business Address 8755 W HIGGINS SUITE 1025 Chicago IL 60631 773-380-6600
Arch Venture Fund VII LP (Filed by) CIK: 0001402439 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13G/A

Mailing Address 620 MEMORIAL DRIVE SUITE 300 CAMBRIDGE MA 02139
Business Address 620 MEMORIAL DRIVE SUITE 300 CAMBRIDGE MA 02139 617-744-1340
Syros Pharmaceuticals, Inc. (Subject) CIK: 0001556263 (see all company filings)

IRS No.: 453772460 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89552 | Film No.: 17600918
SIC: 2834 Pharmaceutical Preparations